Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Atp5mc1 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5MC1 mRNA | CTD | PMID:36331819 | Atp5mc1 | Rat | 1,2,4-trichloro-5-(2,5-dichlorophenyl)benzene | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Atp5mc1 | Rat | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of ATP5MC1 mRNA | CTD | PMID:16174780|PMID:19400957 | Atp5mc1 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MC1 mRNA | CTD | PMID:17942748 | Atp5mc1 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of ATP5MC1 mRNA | CTD | PMID:17555576 | Atp5mc1 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of ATP5MC1 mRNA | CTD | PMID:16174780|PMID:17942748|PMID:19400957 | Atp5mc1 | Rat | 17beta-estradiol | affects expression | EXP | | 6480464 | Estradiol affects the expression of ATP5MC1 mRNA | CTD | PMID:32145629 | Atp5mc1 | Rat | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Atp5mc1 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether affects the expression of ATP5MC1 mRNA | CTD | PMID:30294300 | Atp5mc1 | Rat | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Atp5mc1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5MC1 mRNA | CTD | PMID:11489354 | Atp5mc1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5MC1 mRNA | CTD | PMID:33387578 | Atp5mc1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ATP5MC1 mRNA | CTD | PMID:17942748 | Atp5mc1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19465110 | Atp5mc1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5MC1 mRNA | CTD | PMID:17942748 | Atp5mc1 | Rat | 2,4,4'-trichlorobiphenyl | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Atp5mc1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | 2,2',4,4',5-brominated diphenyl ether affects the expression of ATP5G1 mRNA | CTD | PMID:38648751 | Atp5mc1 | Rat | 2-nitrofluorene | decreases expression | EXP | | 6480464 | 2-nitrofluorene results in decreased expression of ATP5MC1 mRNA | CTD | PMID:14600272 | Atp5mc1 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of ATP5MC1 mRNA | CTD | PMID:26251327 | Atp5mc1 | Rat | 4,4'-diaminodiphenylmethane | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ATP5MC1 mRNA | CTD | PMID:18648102 | Atp5mc1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [bisphenol S co-treated with Tretinoin] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:30951980 | Atp5mc1 | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | ATP5MC1 (Homo sapiens) | 6480464 | bisphenol S results in increased methylation of ATP5MC1 gene | CTD | PMID:31601247 | Atp5mc1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ATP5MC1 mRNA | CTD | PMID:39298647 | Atp5mc1 | Rat | 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one | decreases expression | EXP | | 6480464 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of ATP5MC1 mRNA | CTD | PMID:14600272 | Atp5mc1 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of ATP5MC1 mRNA | CTD | PMID:30047161 | Atp5mc1 | Rat | acetamide | decreases expression | EXP | | 6480464 | acetamide results in decreased expression of ATP5MC1 mRNA | CTD | PMID:31881176 | Atp5mc1 | Rat | aflatoxin B1 | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Aflatoxin B1 results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19770486 | Atp5mc1 | Rat | all-trans-retinoic acid | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of ATP5MC1 mRNA; [bisphenol S co-treated more ... | CTD | PMID:30951980 | Atp5mc1 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:35163327 | Atp5mc1 | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of ATP5MC1 mRNA | CTD | PMID:30047161 | Atp5mc1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ATP5MC1 mRNA | CTD | PMID:16483693 | Atp5mc1 | Rat | Aroclor 1254 | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of ATP5MC1 mRNA | CTD | PMID:23650126 | Atp5mc1 | Rat | arsane | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Arsenic affects the expression of ATP5MC1 mRNA | CTD | PMID:18414638 | Atp5mc1 | Rat | arsenic atom | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Arsenic affects the expression of ATP5MC1 mRNA | CTD | PMID:18414638 | Atp5mc1 | Rat | arsenite(3-) | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to ATP5MC1 mRNA] | CTD | PMID:32406909 | Atp5mc1 | Rat | arsenous acid | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19422848 | Atp5mc1 | Rat | atrazine | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Atrazine results in decreased expression of ATP5MC1 mRNA | CTD | PMID:22378314 | Atp5mc1 | Rat | azoxystrobin | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 | Atp5mc1 | Rat | benzo[a]pyrene | increases methylation | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ATP5MC1 3' UTR | CTD | PMID:27901495 | Atp5mc1 | Rat | benzo[a]pyrene | decreases methylation | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of ATP5MC1 exon | CTD | PMID:27901495 | Atp5mc1 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of ATP5G1 mRNA | CTD | PMID:33754040 | Atp5mc1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ATP5MC1 mRNA | CTD | PMID:25181051 | Atp5mc1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of ATP5MC1 mRNA | CTD | PMID:34947998 | Atp5mc1 | Rat | bisphenol A | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [bisphenol A co-treated with Tretinoin] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:30951980 | Atp5mc1 | Rat | bisphenol A | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | bisphenol A results in decreased expression of ATP5MC1 mRNA | CTD | PMID:35598803 | Atp5mc1 | Rat | bisphenol A | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of ATP5MC1 mRNA | CTD | PMID:29275510 | Atp5mc1 | Rat | bisphenol A | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | bisphenol A affects the expression of ATP5MC1 mRNA | CTD | PMID:30903817 | Atp5mc1 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ATP5MC1 mRNA | CTD | PMID:32145629 | Atp5mc1 | Rat | Butylbenzyl phthalate | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | butylbenzyl phthalate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:28392331 | Atp5mc1 | Rat | cadmium atom | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP5MC1 more ... | CTD | PMID:37236586 | Atp5mc1 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of ATP5MC1 mRNA | CTD | PMID:21297351 | Atp5mc1 | Rat | cadmium dichloride | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ATP5MC1 more ... | CTD | PMID:37236586 | Atp5mc1 | Rat | carbon nanotube | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Nanotubes, Carbon results in decreased expression of ATP5MC1 mRNA | CTD | PMID:25554681 | Atp5mc1 | Rat | carbon nanotube | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Nanotubes, Carbon analog affects the expression of ATP5MC1 mRNA | CTD | PMID:25554681 | Atp5mc1 | Rat | celastrol | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | celastrol inhibits the reaction [Dietary Fats results in decreased expression of ATP5MC1 mRNA] | CTD | PMID:35679966 | Atp5mc1 | Rat | CGP 52608 | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to ATP5MC1 gene] | CTD | PMID:28238834 | Atp5mc1 | Rat | chlorpyrifos | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 | Atp5mc1 | Rat | chlorpyrifos | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ATP5MC1 mRNA | CTD | PMID:32715474 | Atp5mc1 | Rat | cisplatin | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of ATP5MC1 mRNA | CTD | PMID:21858171 | Atp5mc1 | Rat | cobalt dichloride | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19320972|PMID:19376846|PMID:22941251 | Atp5mc1 | Rat | copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ATP5MC1 mRNA | CTD | PMID:22465980 | Atp5mc1 | Rat | copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of ATP5MC1 mRNA | CTD | PMID:22465980 | Atp5mc1 | Rat | copper(II) sulfate | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19549813 | Atp5mc1 | Rat | coumestrol | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5MC1 mRNA; [Coumestrol co-treated with resveratrol] more ... | CTD | PMID:19167446 | Atp5mc1 | Rat | coumestrol | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Coumestrol results in increased expression of ATP5MC1 mRNA | CTD | PMID:19167446 | Atp5mc1 | Rat | cyclosporin A | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of ATP5MC1 mRNA | CTD | PMID:20106945|PMID:22147139|PMID:25562108 | Atp5mc1 | Rat | DDE | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased expression of ATP5MC1 mRNA | CTD | PMID:38568856 | Atp5mc1 | Rat | diarsenic trioxide | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Arsenic Trioxide results in decreased expression of ATP5MC1 mRNA | CTD | PMID:19422848 | Atp5mc1 | Rat | Dibutyl phosphate | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of ATP5MC1 mRNA | CTD | PMID:37042841 | Atp5mc1 | Rat | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:21266533 | Atp5mc1 | Rat | dibutyl phthalate | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:21266533 | Atp5mc1 | Rat | diquat | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Diquat results in increased expression of ATP5MC1 protein | CTD | PMID:36851058 | Atp5mc1 | Rat | dorsomorphin | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Atp5mc1 | Rat | doxorubicin | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of ATP5MC1 mRNA | CTD | PMID:29803840 | Atp5mc1 | Rat | doxorubicin | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of ATP5MC1 protein | CTD | PMID:29385562 | Atp5mc1 | Rat | Enterolactone | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of ATP5MC1 mRNA | CTD | PMID:19167446 | Atp5mc1 | Rat | ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of ATP5MC1 mRNA | CTD | PMID:15353170 | Atp5mc1 | Rat | ethyl methanesulfonate | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:23649840 | Atp5mc1 | Rat | fipronil | decreases expression | EXP | | 6480464 | fipronil results in decreased expression of ATP5MC1 mRNA | CTD | PMID:23962444 | Atp5mc1 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of ATP5MC1 mRNA | CTD | PMID:24136188 | Atp5mc1 | Rat | formaldehyde | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of ATP5MC1 mRNA | CTD | PMID:23649840 | Atp5mc1 | Rat | genistein | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:21782745 | Atp5mc1 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of ATP5MC1 mRNA | CTD | PMID:22061828 | Atp5mc1 | Rat | glafenine | increases expression | EXP | | 6480464 | Glafenine results in increased expression of ATP5MC1 mRNA | CTD | PMID:24136188 | Atp5mc1 | Rat | glyphosate | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 | Atp5mc1 | Rat | imidacloprid | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 | Atp5mc1 | Rat | isoniazide | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Isoniazid affects the expression of ATP5MC1 mRNA | CTD | PMID:24848797 | Atp5mc1 | Rat | isoprenaline | multiple interactions | EXP | | 6480464 | [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:30303030 | Atp5mc1 | Rat | leflunomide | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Leflunomide results in decreased expression of ATP5MC1 mRNA | CTD | PMID:28988120|PMID:29427785 | Atp5mc1 | Rat | lipopolysaccharide | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:31059760 | Atp5mc1 | Rat | maneb | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:18386188 | Atp5mc1 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of ATP5MC1 mRNA | CTD | PMID:30047161 | Atp5mc1 | Rat | methoxychlor | multiple interactions | EXP | | 6480464 | [Genistein co-treated with Methoxychlor] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:21782745 | Atp5mc1 | Rat | methyl methanesulfonate | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of ATP5MC1 mRNA | CTD | PMID:23649840 | Atp5mc1 | Rat | methylparaben | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | methylparaben results in decreased expression of ATP5MC1 mRNA | CTD | PMID:38568856 | Atp5mc1 | Rat | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of ATP5MC1 mRNA | CTD | PMID:14600272 | Atp5mc1 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of ATP5MC1 mRNA | CTD | PMID:24136188 | Atp5mc1 | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of ATP5MC1 mRNA | CTD | PMID:24136188 | Atp5mc1 | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of ATP5MC1 mRNA | CTD | PMID:33484710 | Atp5mc1 | Rat | paracetamol | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Acetaminophen affects the expression of ATP5MC1 mRNA | CTD | PMID:25704631 | Atp5mc1 | Rat | paracetamol | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of ATP5MC1 mRNA | CTD | PMID:29067470|PMID:31059760 | Atp5mc1 | Rat | paracetamol | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:31059760 | Atp5mc1 | Rat | paraquat | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [Paraquat co-treated with Maneb] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:18386188 | Atp5mc1 | Rat | PCB138 | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with more ... | CTD | PMID:25510870 | Atp5mc1 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Atp5mc1 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of ATP5MC1 mRNA | CTD | PMID:36331819 | Atp5mc1 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of ATP5MC1 mRNA | CTD | PMID:35163327 | Atp5mc1 | Rat | phenobarbital | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of ATP5MC1 mRNA | CTD | PMID:19159669 | Atp5mc1 | Rat | PhIP | increases expression | EXP | | 6480464 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in increased expression of ATP5MC1 mRNA | CTD | PMID:15215175 | Atp5mc1 | Rat | piroxicam | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Piroxicam co-treated with Cisplatin] results in increased expression of ATP5MC1 mRNA | CTD | PMID:21858171 | Atp5mc1 | Rat | potassium dichromate | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Potassium Dichromate results in increased expression of ATP5MC1 mRNA | CTD | PMID:11678601 | Atp5mc1 | Rat | quercetin | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of ATP5MC1 mRNA | CTD | PMID:21632981 | Atp5mc1 | Rat | resveratrol | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of ATP5MC1 mRNA | CTD | PMID:19167446 | Atp5mc1 | Rat | resveratrol | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Resveratrol results in increased expression of ATP5MC1 mRNA | CTD | PMID:22610192 | Atp5mc1 | Rat | SB 431542 | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Atp5mc1 | Rat | silver atom | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Silver affects the expression of ATP5MC1 mRNA | CTD | PMID:27131904 | Atp5mc1 | Rat | silver(0) | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Silver affects the expression of ATP5MC1 mRNA | CTD | PMID:27131904 | Atp5mc1 | Rat | sodium arsenite | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of ATP5MC1 mRNA | CTD | PMID:28595984 | Atp5mc1 | Rat | sodium arsenite | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of ATP5G1 mRNA | CTD | PMID:38685555 | Atp5mc1 | Rat | sodium arsenite | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | sodium arsenite affects the expression of ATP5MC1 mRNA | CTD | PMID:34032870 | Atp5mc1 | Rat | sodium arsenite | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of ATP5MC1 mRNA | CTD | PMID:38568856 | Atp5mc1 | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of ATP5MC1 mRNA | CTD | PMID:30047161 | Atp5mc1 | Rat | sulforaphane | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | sulforaphane results in increased expression of ATP5MC1 mRNA | CTD | PMID:30529165 | Atp5mc1 | Rat | sunitinib | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of ATP5MC1 mRNA | CTD | PMID:31533062 | Atp5mc1 | Rat | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of ATP5MC1 mRNA | CTD | PMID:19400957 | Atp5mc1 | Rat | tamoxifen | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tamoxifen results in increased expression of ATP5MC1 mRNA | CTD | PMID:19400957 | Atp5mc1 | Rat | tamoxifen | affects expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tamoxifen affects the expression of ATP5MC1 mRNA | CTD | PMID:17555576 | Atp5mc1 | Rat | tetrachloroethene | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of ATP5MC1 mRNA | CTD | PMID:28973375 | Atp5mc1 | Rat | thapsigargin | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of ATP5MC1 mRNA | CTD | PMID:22378314 | Atp5mc1 | Rat | thiabendazole | multiple interactions | EXP | | 6480464 | [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with more ... | CTD | PMID:33854195 | Atp5mc1 | Rat | thiram | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Thiram results in decreased expression of ATP5MC1 mRNA | CTD | PMID:38568856 | Atp5mc1 | Rat | titanium dioxide | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ATP5MC1 mRNA | CTD | PMID:23557971 | Atp5mc1 | Rat | trichloroethene | decreases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Trichloroethylene results in decreased expression of ATP5MC1 mRNA | CTD | PMID:28973375 | Atp5mc1 | Rat | tungsten | increases expression | ISO | Atp5mc1 (Mus musculus) | 6480464 | Tungsten results in increased expression of ATP5MC1 mRNA | CTD | PMID:30912803 | Atp5mc1 | Rat | tunicamycin | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of ATP5MC1 mRNA | CTD | PMID:22378314 | Atp5mc1 | Rat | urethane | decreases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ATP5MC1 mRNA | CTD | PMID:28818685 | Atp5mc1 | Rat | valproic acid | affects expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of ATP5MC1 mRNA | CTD | PMID:25979313 | Atp5mc1 | Rat | valproic acid | increases expression | ISO | ATP5MC1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ATP5MC1 mRNA | CTD | PMID:23179753|PMID:25192806|PMID:26272509|PMID:28001369 | Atp5mc1 | Rat | valproic acid | multiple interactions | ISO | ATP5MC1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | |






















